Extended pelvic lymphadenectomy does not improve biochemical recurrence in high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a propensity-matched comparison of two institutions
In this study, ePLND for high- or very high-risk prostate cancer did not improve BCR. However, it may improve BCR in very high-risk prostate cancer.
Authors
- Haruka Miyai
- Takahito Wakamiya (ORCID: https://orcid.org/0000-0001-9101-1749)
- Isao Hara (ORCID: https://orcid.org/0000-0003-4542-4045)
- Masaya Nishihata
- Yasuo Kohjimoto (ORCID: https://orcid.org/0000-0001-6103-6320)
- Shimpei Yamashita (ORCID: https://orcid.org/0000-0001-7402-6164)
- Sohei Iwagami (ORCID: https://orcid.org/0009-0000-1841-1121)
Institutions
- Wakayama Medical University (JP)
- Kishiwada Tokushukai Hospital (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1093/jjco/hyaf100
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00